These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11737617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
    Kaneko Y, Miyazaki S, Hirasawa Y, Gejyo F, Suzuki M.
    Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content.
    Mitsuiki K, Harada A, Miyata Y.
    Clin Exp Nephrol; 2003 Mar; 7(1):52-7. PubMed ID: 14586744
    [Abstract] [Full Text] [Related]

  • 6. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR, DRIVE Study Group.
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [Abstract] [Full Text] [Related]

  • 7. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 8. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D, Johnson CA, Wish JB, Rocco MV, Madore F, Owen WF.
    Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
    [Abstract] [Full Text] [Related]

  • 9. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

  • 10.
    Chung M, Moorthy D, Hadar N, Salvi P, Iovin RC, Lau J.
    ; 2012 10. PubMed ID: 23230575
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of iron indices in hemodialysis patients receiving epoetin.
    Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA, Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.
    Kidney Int; 2001 Jul; 60(1):300-8. PubMed ID: 11422765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients.
    Low CL, Bailie GR, Eisele G.
    Ren Fail; 1997 Nov; 19(6):781-8. PubMed ID: 9415935
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.
    Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, Zazra JJ, Anandan JV, Gupta A.
    J Am Soc Nephrol; 2000 Mar; 11(3):530-538. PubMed ID: 10703677
    [Abstract] [Full Text] [Related]

  • 19. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C, Tsuchiya K, Tomosugi N, Kanda F, Maeda K, Maeda T.
    PLoS One; 2017 Mar; 12(6):e0179608. PubMed ID: 28662118
    [Abstract] [Full Text] [Related]

  • 20. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Fishbane S, Frei GL, Maesaka J.
    Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.